A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 in Japanese Healthy Participants With Single and Multiple Ascending Dose Administration

NCT03801967 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: AZD9977
DRUG: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]